You are here
ISSCR 2016Jun 22 - Jun 25, 2016
The ISSCR is the premier international society for stem cell science, an organization dedicated to a concerted international approach to advancing research towards new therapies.
The ISSCR Annual Meeting provides an opportunity for scientists, clinicians, educators and industry professionals to share new data, learn from peers, and discover global advances within the stem cell field. With over 4000 professionals from 60 countries, the ISSCR 2016 Annual Meeting is the global source of the discoveries that are the basis for treatments of tomorrow.
Clinical Application of CAR T CellsMar 10 - Mar 11, 2016
Chimeric antigen receptor (CAR) T-cell (’Living Drug’) immunotherapy is showing promising results in the treatment of cancers. There are nine ongoing clinical trials (Phase I & II) at Memorial Sloan Kettering (MSK) and more on track to be initiated next year.
Over the years, MSK has accumulated a breadth of knowledge about developing and translating these clinical trials from bench to bedside – choosing the ideal antigen target, constructing clinical grade CARs and vectors, investigating in clinically relevant models, manufacturing, quality control, developing protocols for FDA approval, optimizing consent forms covering emerging ethical issues, managing complications, and conducting world-class correlative science.
In addition to the MSK faculty, national and international experts will discuss clinical and translational aspects of CARs, both for hematological malignancies and solid tumors.
The target audience is medical oncologists and oncology fellows in training, basic scientists and research fellows in training, immunologists, and surgeons with interest in tumor immunology and immunotherapy.
MSK is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
Click here to view the save the date brochure (PDF)